Residual risk in patients treated with statins from the very high risk group of development atherogenic dyslipidemia. A prospective study "CRYSTAL" Part 1: Purpose, objectives, design, and baseline characteristics of the included patients

Authors

  • M. Yu. Zubareva Russian Cardiology Research Complex
  • T. A. Rozhkova Russian Cardiology Research Complex
  • N. B. Gornyakova Russian Cardiology Research Complex
  • E. Yu. Solov'eva Russian Cardiology Research Complex
  • V. V. Kukharchuk Лаборатория клинической липидологии, отдел атеросклероза. ФГБУ
  • V. A. Amelyushkina Russian Cardiology Research Complex
  • T. И. Kotkina Russian Cardiology Research Complex
  • V. N. Titov Russian Cardiology Research Complex
  • A. V. Susekov Russian Cardiology Research Complex

Keywords:

residual risk, atherogenic dyslipidemia, statins, CRYSTAL, prospective study

Abstract

This article is the first publication of data of a prospective, observational study "CRYSTAL" - the study of residual
risk in patients with very high risk of cardiovascular disease and atherogenic dyslipidemia, treated with statins. The
description of the purpose, objectives, design, and baseline characteristics included major patients. The data are
compared with the results of Russian and International Studies of residual cardiovascular risk factors.

Downloads

Download data is not yet available.

Downloads

Published

2013-03-30

How to Cite

Zubareva M. Y., Rozhkova T. A., Gornyakova N. B., Solov’eva E. Y., Kukharchuk V. V., Amelyushkina V. A., Kotkina T. И., Titov V. N., Susekov A. V. Residual risk in patients treated with statins from the very high risk group of development atherogenic dyslipidemia. A prospective study "CRYSTAL" Part 1: Purpose, objectives, design, and baseline characteristics of the included patients // The Journal of Atherosclerosis and Dyslipidemias. 2013. VOL. № 1 (10). PP. 26–34.

Issue

No. 1 (10) (2013)

Section

Original research paper

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 > >>